1. Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009;80(6):609.
2. Berria M. Cervical, ovarian, and uterine cancers. Salem Press; 2013.
http://search.ebscohost.com/login.aspx?direct=true&db=ers&AN=86193973&lang=zh-cn&site=eds-live
.
3. Moss EL, Hollingworth J, Reynolds TM. The role of CA125 in clinical practice. J Clin Pathol. 2005;58(3):308–12.
4. Jr NB, Krasznai ZT, Balla H, Csobán M, Antal-Szalmás P, Hernádi Z, Kappelmayer J. Elevated human epididymis protein 4 concentrations in chronic kidney disease. Ann Clin Biochem. 2012;49(Pt 4):377.
5. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban N. Use of a symptom index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol. 2010;116(3):378–83.